XXVII Reunión anual de la sección de Hemodinámica y Cardiología Intervencionista 16 y 17 de junio de 2016 León http://secardiologia.es/xxvii-reunion-anual-de-la-seccion-de-hemodinamica-y-cardiologia-intervencionista REPARA. Registro de paciEntes con dispositivo biorreabsorbible en la Práctica clínica habitual

1. Registro de pacientes con Dispositivo
Biorreabsorbible en la práctica
clínica habitual
Felipe Hernández Hernández, en representación de los
investigadores de REPARA

2. REPARA (F. Hernandez)
Objective: Evaluate the safety and efficacy of BVS usage in real world patients under
well-controlled implementation criteria.
Design: Prospective, Open-Label, Multi Center, Iberian registry in 1500 Pts, 60 Spanish sites
Primary Endpoint: MACE rate (major adverse cardiac events) at 12 months of follow-up:
Cardiac death; Myocardial infarction; Target lesion revascularisation
(TLR) ischemia-driven: Cardiac Death/All MI/ID-TLR
Secondary
Endpoints:
Components: Death (Cardiovascular, Non-Cardiovascular), Myocardial
Infarction (MI: QMI and NQMI, TV,…), Angina, DAPT rates and
relationship to events
Clinical follow-up
30dy 6mo 1yr
Primary Endpoint
Absorb
18 septiembre 2015: final inclusión pacientes
2448 patients

3. Variables n=3370
Radial access (%) 84.4
Diseased vessels pr patient (n) 1.5 ± 0.7
Treated lesions (n) 3370
Treated lesions per patient (n) 1.38 ± 0.71
Vessel distribution (%)
 LAD 52.9
 CX 20.6
 RCA 26.5
Lesion type (%)
 A/B1 58.4
 B2/C 41.6
Predilatation (%) 77.5
Lesion length (mm) 18.3 ± 9.4
Devices per patient (n) 1.6 ± 0.5
Implanted stents (n) 3950
 Absorb (%) 83.0
 DES (%) 15.5
 BMS (%) 1.4
Device length (mm) 23.8 ± 13.1
Device size (mm) 3.0 ± 0.4
Postdilatation (%) 45.6
Postdilatation pressure (atm) 17.7 ± 5.1
Overlapping (%) 16.5
Bifurcations (%) 18.4
Moderate-severe tortuosity (%) 11.7
Moderate-severe calcification (%) 8.9
Intravascular imaging (%) 11.1
- IVUS 2.5
- OCT 8.6
Procedural success (%) 98.9

4. MACE at 30 days n %
 Myocardial infarction (%) 36 1.5
 All deaths (%) 11 0.4
 Cardiac deaths (%) 7 0.3
 Device thrombosis (%) 22 0.9
 TLR (%) 20 0.8
Global population
Immediate procedural success 98.9%

5. Publicaciones
Comunicaciones orales presentadas en
ESC 2015
SEC 2015
TCT 2015
EuroPCR 2016
Manuscrito en preparación (resultados inmediatos y a
30 días)
Análisis específico de subgrupos: STEMI, DM,
bifurcaciones, overlapping